NHI payment possibility for anti-obesity medications attracts keen interests.

On July 25 the Seoul District Administrative Court decided that the anti-obesity medication should be deemed as an eligible subject to include the NHI reimbursement scheme unless the treatment was purported for an aesthetic surgical operation such as an abdominal extra fat suction. Since then, the possibility for the anti-obesity drug medication to pay by the NHI plan attracts keen public inter...